secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001493152-24-015344
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioxytran creates insider-only convertible preferred with 10 votes per share; appoints Dr. Radka Milanova to board
--------------------------------------------------------------------------------

- Board designated 49.5M of 50M authorized preferred shares as Convertible Preferred Stock with 10 votes per share on as-converted basis.
- Exchange ratio: 5 common shares for 1 preferred share; conversion ratio: 1 preferred share for 5 common shares.
- Only common shares held by insiders (officers, directors) are eligible to exchange into the new preferred stock.
- Dr. Radka Milanova (PhD, Organic Chemistry) appointed to fill board vacancy left by deceased Dr. Chen-Walden.
- Dr. Milanova receives $5,000 in common stock per attended board/committee meeting; no cash compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000149315224015344/0001493152-24-015344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000149315224015344/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer